3[3]Lundell LR,Dent J,Bennett JR,Blum AL,Armstrong D,Galmiche JP,Johnson F,Hongo M,Richter JE,Spechler SJ,Tytgat GN,Wallin L.Endoscopic assessment of oesophagitis:clinical and functional correlates and further validation of the Los Angeles classification.Gut 1999; 45:172-180
4[4]Adachi K,Fujishiro H,Katsube T,Yuki M,Ono M,Kawamura A,Rumi MA,Watanabe M,Kinoshita Y.Predominant nocturnal acid reflux in patients with Los Angeles grade C and D reflux esophagitis.J Gastroenterol Hepatol 2001; 16:1191-1196
6[6]Wiklund I,Bardhan KD,Muller-Lissner S,Bigard MA,Bianchi Porro G,Ponce J,Hosie J,Scott M,Weir D,Fulton C,Gillon K,Peacock R.Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine.Results from a multicentre clinical trial.The European Study Group.Ital J Gastroenterol Hepatol 1998; 30:19-27
7[7]Matthews PJ,Aziz Q,Facet P,Davis JB,Thompson DG,Anand P.Increased capsaicin receptor TRPV1 nerve fibres in the inflamed human oesophagus.Eur J Gastroenterol Hepatol 2004; 16:897-902
8Rey E, Garcia-Alonso M, Moreno-Ortega M, et al. Influence of psychological distress on characteristics of symptoms in pa- tients with GERD :the role of IBS comorbidity [J]. Dig Dis Sci, 2009,54(2) : 321-327.
9Shaw M J, Talley N J, Beebe TJ, et al. Initial validation of a di- agnostic questionnaire for gastroesphageal reflux disease [J]. Am J Gastroenterol, 2001,96 ( 1 ) :52-57.
